Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
AI can identify women at a high risk of developing breast cancer more accurately than existing prediction models, according to a new study published in Radiology.
Machine learning (ML) algorithms can evaluate cardiac MR (CMR) images and provide accurate measurements of left ventricular (LV) volumes from throughout the patient’s cardiac cycle, according to a new study published in Magnetic Resonance Imaging.
Machine learning models can be trained to predict chronic diseases such as dementia using electronic medical record (EMR) data, according to a new study published in Artificial Intelligence in Medicine.
CVS Health launched a new precision medicine strategy for payors called Transform Oncology Care, using genomic testing results at the point-of-prescribing for targeted treatments.
Oncopole, a Montreal-based research center, announced that five teams won the Onco-Tech Competition and will receive a total of $1.97 ($2.6 million CAD) in funding.
Civica Rx, the not-for-profit drug company startup created by a group of hospitals and health systems to reduce drug shortages, is prepared to ship its first eight injectable medicines.
Humana is launching two new partnerships in four states to better care for its Medicare Advantage and commercially insured members who have kidney care.
